✦ LIBER ✦

Detection of metachronous esophageal squamous carcinoma in patients with head and neck cancer with use of transnasal esophagoscopy

✍ Scribed by Yan-Ye Su; Fu-Min Fang; Hui-Ching Chuang; Sheng-Dean Luo; Chih-Yen Chien

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 113 KB
Volume: 32
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.21252

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

The use of transnasal esophagoscopy was examined for detecting metachronous esophageal squamous carcinoma in patients with head and neck squamous cell carcinoma (HNSCC).

Methods

In all, 398 transnasal esophagoscopies were performed in 293 previously treated patients with HNSCC between December 2007 and January 2009.

Results

Metachronous esophageal squamous carcinoma was detected in 15 (5.1%) patients. The prevalence rate was 15.9% (7/44) in patients with hypopharyngeal cancer, significantly higher than the 8.3% (2/24) with laryngeal, 7.1% (3/42) with oropharyngeal, and 1.6% (3/183) with oral cancer (p = .001). The stage distributions of esophageal squamous carcinoma were I–II in 12 (80%) and III–IV in 3 (20%) patients. Subsequently, curative strategies were performed in 13 (87%) patients.

Conclusions

Transnasal esophagoscopy can be used as a routine survey technique in patients with HNSCC to detect metachronous esophageal squamous carcinoma, especially in those with hypopharyngeal cancer. © 2009 Wiley Periodicals, Inc. Head Neck, 2010

📜 SIMILAR VOLUMES

Efficacy of neck treatment in patients w

Efficacy of neck treatment in patients with head and neck squamous cell carcinoma

✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Esophageal squamous cell cancer in patie

Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences

✍ Ethel-Michele de Villiers; Karin Gunst; Harald Stein; Hans Scherübl 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 2 views

## Abstract An etiologic role for human papillomavirus (HPV) infections in either head and neck (HNC) or esophageal carcinogenesis remains debatable. Patients with head and neck cancer are at high risk for developing a second esophageal squamous cell cancer (ESCC). The aim of our study was to deter

Detection of MAGE-4 protein in sera of p

Detection of MAGE-4 protein in sera of patients with head-and-neck squamous-cell carcinoma

✍ Osamu Iwamoto; Yumiko Nagao; Shigeki Shichijo; Masao Eura; Tadamitsu Kameyama; K 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 123 KB 👁 2 views

The MAGE-4 gene, a member of the MAGE gene family, is expressed in various cancers, including head-and-neck squamous-cell carcinomas (HN-SCC), but is not expressed in any normal tissues except for the testis and placenta. The aim of this study was to determine whether serum MAGE-4 protein is a usefu

Treatment of the neck in patients with s

Treatment of the neck in patients with squamous cell carcinoma of the head and neck

✍ Richard H. Jesse; Gilbert H. Fletcher 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

Detection of synchronous lung tumors in

Detection of synchronous lung tumors in patients presenting with squamous cell carcinoma of the head and neck

✍ Samit K. Ghosh; Nicholas J. Roland; Aman Kumar; Sankalap Tandon; Jeffrey L. Lanc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## __Background.__ Screening for synchronous pulmonary tumors in patients presenting with squamous cell carcinoma of the head and neck (SCCHN) is important, because detection may alter subsequent management. ## __Methods.__ We conducted a retrospective review, comparing effectiveness

Immunoglobulin allotypes in patients wit

Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck

✍ Theodorus Ockhuizen; Janardan P. Pandey; Robert W. Veltri; Myron Arlen; H. Hugh 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant